Patents by Inventor Daniel Schramek

Daniel Schramek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BREAST CANCER THERAPEUTICS
    Publication number: 20190030161
    Abstract: The present invention relates to a method of treating or preventing cancer in a subject comprising administering a therapeutically effective amount of a RANKL inhibitor to said patient.
    Type: Application
    Filed: October 12, 2018
    Publication date: January 31, 2019
    Applicant: IMBA - INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH
    Inventors: Josef PENNINGER, Daniel SCHRAMEK
  • Breast cancer therapeutics
    Patent number: 10143747
    Abstract: The present invention relates to a method of treating or preventing cancer in a subject comprising administering a therapeutically effective amount of a RANKL inhibitor to said patient.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: December 4, 2018
    Assignee: IMBA—INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH
    Inventors: Josef Penninger, Daniel Schramek
  • BREAST CANCER DIAGNOSTICS USING RANKL AND OPG
    Publication number: 20170102388
    Abstract: The present invention relates to methods and means for detecting cancer or of predicting a patient developing cancer or of determining the rate of progression of cancer in a patient suffering from cancer, comprising determining RANKL activity and/or the amount of OPG in a sample of said patient.
    Type: Application
    Filed: December 27, 2016
    Publication date: April 13, 2017
    Applicant: IMBA - INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH
    Inventors: Josef PENNINGER, Daniel SCHRAMEK, Georg SCHETT, Martin WIDSCHWENDTER, Ian J. JACOBS, Usha MENON
  • COMPOSITIONS AND METHODS FOR DIAGNOSIS AND THERAPY OF DISORDERS RELATED TO ALTERATIONS OF MYH9
    Publication number: 20150148411
    Abstract: Provided are compositions and methods related to mutations in the Myh9 gene for aiding in diagnosing a subject as having an aggressive form of a cancer, for identifying an individual as a candidate for treatment with a nuclear export inhibitor, for determining whether tumor cells have defective p53 nuclear transportation, and for treating an individual diagnosed with an aggressive cancer.
    Type: Application
    Filed: November 25, 2014
    Publication date: May 28, 2015
    Inventors: Daniel Schramek, Elaine Fuchs
  • BREAST CANCER DIAGNOSTICS
    Publication number: 20130316374
    Abstract: The present invention relates to methods and means for detecting cancer or of predicting a patient developing cancer or of determining the rate of progression of cancer in a patient suffering from cancer, comprising determining RANKL activity and/or the amount of OPG in a sample of said patient.
    Type: Application
    Filed: September 22, 2011
    Publication date: November 28, 2013
    Applicant: IMBA - INSTITUT FUR MOLEKULARE BIOTECHNOLOGIE GMBH
    Inventors: Josef Penninger, Daniel Schramek, Georg Schett, Martin Widschwendter, Ian J. Jacobs, Usha Menon
  • BREAST CANCER THERAPEUTICS
    Publication number: 20130216550
    Abstract: The present invention relates to a method of treating or preventing cancer in a subject comprising administering a therapeutically effective amount of a RANKL inhibitor to said patient.
    Type: Application
    Filed: September 22, 2011
    Publication date: August 22, 2013
    Applicant: IMBA-INSTITUT FUR MOLEKULARE BIOTECHNOLOGIE GMBH
    Inventors: Josef Penninger, Daniel Schramek